Home
About Journal
Journal Introduction
Editorial Board
Youth Editorial Board
Cooperating Institutions
Editorial Department
Submission Guidelines
Policies & Statements
Ethical Guidelines for Publication
Academic Misconduct Statement
Open Access (OA) Statement
AIGC Use Statement
Journal Subscription
Download Center
中文版
Cite this article:
.[J].Journal Of Pharmaceutical Research,2013,32(1):19
[
Click to copy
]
【Print this page】
【Download PDF Full Text】
【
View/Add Comment
】
【
Download reader
】
【
Close
】
←Previous
|
Next→
Archive
Advanced Search
This article has been viewed:
2581
times Download
2288
次
Scan with your phone!
FDA批准Promacta治疗慢性丙型肝炎患者的血小板减少症
Font:
Larger+
|
Default
|
Smaller-
()
摘要
:
关键词
:
慢性丙型肝炎
FDA
Promacta
Ⅲ期临床试验
持续病毒学应答
安慰剂对照
葛兰素史克
血小板生成素
受体激动剂
外周水肿
DOI:
10.13506/j.cnki.jpr.2013.01.025
基金项目
:
()
Abstract
:
Key words
: